WCN26-4494 ENHANCEMENT OF ATRAP IN THE DISTAL NEPHRON SUPPRESSES ANGIOTENSIN II–INDUCED HYPERTENSION

Read full text Summarise with VIRAT
Authors: Eisuke Kubo, Hiromichi Wakui, Akio Yamashita, Kengo Azushima, Kotaro Haruhara, Takashi Yokoo, Kouichi Tamura
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The renal tubular renin-angiotensin system (RAS), via angiotensin II type1 receptor (AT1R) signaling, promote sodium reabsorption, hypertension, and target-organ damage. Sodium transporters such as NCC and ENaC are regulated downstream of this pathway. However, the detailed molecular mechanisms controlling their expression and activity remain incompletely understood. ATRAP (AT1R-associated protein) is an endogenous modulator that suppresses pathological AT1R signaling. We have previously demonstrated that dysregulation of renal ATRAP induces hypertension under various pathological conditions, probably through modulation of sodium transporters (Hypertension 2013; Kidney Int 2014, 2017, 2022; J Biol Chem 2023).

Fields of Study & Subjects

Renin-Angiotensin System Studies Ion Transport and Channel Regulation Blood Pressure and Hypertension Studies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105033–105033
Publication date
25 March 2026
Language
EN